General - Press Releases

Date	Title	Company
06-Dec-2025	Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma	Businesswire
06-Dec-2025	Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting	Businesswire
06-Dec-2025	Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)	Businesswire
06-Dec-2025	Orca Bio Presents New Clinical Data on Orca-T® in Older Patients Using Reduced Intensity Conditioning Plus New Analyses from the Precision-T Phase 3 Study at the 67th ASH Annual Meeting	Businesswire
06-Dec-2025	Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera	Businesswire
06-Dec-2025	Genetix Participates in the American Society of Hematology’s (ASH) Exclusive Press Program & Shares Recent Patient Experience Data from U.S. Commercial Gene Therapy Implementation	Businesswire
06-Dec-2025	Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions	Businesswire
05-Dec-2025	Mice Model Market Trends and Growth Opportunities by Segment & Region 2025-2032 - Transformative Innovations in Genetic Engineering Propel Mice Model Research in Oncology and Rare Diseases - ResearchAndMarkets.com	Businesswire
05-Dec-2025	Encoded Therapeutics Presents Positive Interim Efficacy Data from Initial Dose Levels of Phase 1/2 Trials Evaluating ETX101 Gene Therapy in Dravet Syndrome	Businesswire
05-Dec-2025	Mango Sciences Announces Partnership With ImmunoACT to Bring the World’s First Bridge Financing Plan and Value-Based Offering for CAR-T Therapy for Cancer Patients in India	Businesswire
05-Dec-2025	Allergy Diagnostics and Therapeutics Market Forecast 2025-2033 - Urbanization and Pollution Drive Allergy Rates, Accelerating Market Expansion at a 9.7% CAGR - ResearchAndMarkets.com	Businesswire
05-Dec-2025	Agricultural Microbials Market Analysis and Investment Opportunities, 2025-2032 - Biotechnology Innovations Drive Growth in Agricultural Microbials, Transforming Agri-Business Strategies - ResearchAndMarkets.com	Businesswire
05-Dec-2025	Arthur D. Little and Vega IT Unveil Joint Venture for Digital Innovation	Businesswire
05-Dec-2025	Industrial Doors Market Research Report 2025-2030 with ASSA ABLOY, Hormann Group, Sanwa Holdings, and Clopay at the Forefront of Innovation and Growth - ResearchAndMarkets.com	Businesswire
05-Dec-2025	Stoke Therapeutics and Biogen Present Data that Further Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 2025 American Epilepsy Society (AES) Annual Meeting	Businesswire
05-Dec-2025	Actio Biosciences Announces Preclinical Data Highlighting Ability of ABS-1230 to Potently and Selectively Inhibit KCNT1 and Significantly Reduce Seizure Activity	Businesswire
05-Dec-2025	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
05-Dec-2025	Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Businesswire
05-Dec-2025	Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL)	Businesswire
05-Dec-2025	IDE034, a Bispecific ADC Licensed by Biocytogen to IDEAYA, Receives FDA IND Clearance	Businesswire